{"id":204,"date":"2026-08-13T13:08:44","date_gmt":"2026-08-13T13:08:44","guid":{"rendered":"https:\/\/leo-pharma.be\/fr-be\/?page_id=204"},"modified":"2026-08-13T13:09:10","modified_gmt":"2026-08-13T13:09:10","slug":"loe-communicatie","status":"publish","type":"page","link":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","title":{"rendered":"LoE Communicatie"},"content":{"rendered":"\n
<\/div>\n\n\n\n

Sujet : changements de prix et de remboursement pour Dovobet\u00ae, Xamiol\u00ae et Enstilum\u00ae<\/h2>\n\n\n\n

Ch\u00e8re,Cher docteur, professeur,<\/p>\n\n\n\n

LEO Pharma investit depuis de nombreuses ann\u00e9es dans le d\u00e9veloppement de m\u00e9dicaments pour les affections cutan\u00e9es. Nos m\u00e9dicaments topiques pour le traitement du psoriasis sont la pierre angulaire du traitement de nombreux patients en Belgique.<\/p>\n\n\n\n

En raison de l’introduction r\u00e9cente sur le march\u00e9 belge d’un g\u00e9n\u00e9rique du Dovobet\u00ae pommade, le syst\u00e8me de remboursement de r\u00e9f\u00e9rence sera appliqu\u00e9 \u00e0 tous les m\u00e9dicaments originaux contenant les principes actifs calcipotriol et b\u00e9tam\u00e9thasone. Cela entra\u00eene une baisse significative du prix de la pommade Dovobet\u00ae, du gel Dovobet\u00ae, de Xamiol\u00ae et d’Enstilum\u00ae (la base de remboursement niveau ex-usine est automatiquement r\u00e9duite de 44,75 %).<\/p>\n\n\n\n

Dovobet\u00ae pommade, Dovobet\u00ae gel et Xamiol\u00ae<\/h2>\n\n\n\n

Pour ces sp\u00e9cialit\u00e9s, nous appliquerons la r\u00e9duction de prix obligatoire. Cela signifie qu’elles restent disponibles et rembours\u00e9es pour vous et vos patients. Le nouveau prix public sera de 24,83 \u20ac (ticket mod\u00e9rateur: Assur\u00e9 pr\u00e9f\u00e9rentiel (\u20ac 3.92), Assur\u00e9 ordinaire (\u20ac 6.58)) \u00e0 partir du 1er f\u00e9vrier 2024.<\/p>\n\n\n\n

Enstilum\u00ae<\/h2>\n\n\n\n

Malgr\u00e9 l’efficacit\u00e9 sup\u00e9rieure et la valeur ajout\u00e9e d’Enstilum\u00ae par rapport au Dovobet\u00ae pommade(1), la r\u00e9duction de prix impos\u00e9e affecte \u00e9galement cette sp\u00e9cialit\u00e9. Malheureusement, nous ne pouvons pas accepter cette r\u00e9duction de prix pour Enstilum\u00ae.<\/p>\n\n\n\n

En raison du dispositif unique et de la formulation innovante (2) (mousse en a\u00e9rosol), le co\u00fbt de production est beaucoup plus \u00e9lev\u00e9 que celui d’une pommade ou d’un gel. De plus, l’impact \u00e9conomique d’une baisse de prix ne se limitera pas \u00e0 la Belgique. D’une part, en raison de la libre circulation des marchandises en Europe et d’autre part, car plusieurs pays se r\u00e9f\u00e8rent aux prix belges pour la fixation du prix de leurs m\u00e9dicaments. Par cons\u00e9quent, une telle baisse de prix en Belgique aurait des cons\u00e9quences \u00e9conomiques consid\u00e9rables pour LEO Pharma.<\/p>\n\n\n\n

Cependant, nous avons cherch\u00e9 une solution alternative pour maintenir \u00e9galement Enstilum\u00ae disponible pour les patients belges.<\/p>\n\n\n\n

Nous avons l’intention de r\u00e9introduire Enstilum\u00ae en tant que m\u00e9dicament non rembours\u00e9 , sous r\u00e9serve de l’approbation du ministre de l\u2019\u00c9conomie et de l’Emploi. Cela signifie qu\u2019 Enstilum\u00ae ne sera pas disponible en Belgique pendant une courte p\u00e9riode.<\/p>\n\n\n\n

Nous sommes conscients que ce n’est pas une solution id\u00e9ale pour vous et vos patients, mais nous esp\u00e9rons que de cette fa\u00e7on, nous pourrons continuer \u00e0 aider un certain nombre de patients belges avec Enstilum\u00ae.<\/p>\n\n\n\n

D\u00e8s qu\u2019Enstilum\u00ae sera \u00e0 nouveau disponible, nous vous tiendrons inform\u00e9 en priorit\u00e9.

<\/p>\n\n\n\n

Si vous avez des questions, n\u2019h\u00e9sitez pas \u00e0 nous contacter :
au +32 (0)3 740 78 68 ou via votre contact commercial\u00a0:
Alajana Mattiello: +32 493 25 02 66
Jean-Luc Julemont: +32 496 40 82 43
Robby Reynaerts: +32 491 90 42 83
Lindsay Van den Bossche: +32 472 88 04 50

<\/p>\n\n\n\n

Cordialement,
LEO Pharma<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n

R\u00e9f\u00e9rence:<\/h2>\n\n\n\n

(1)\u00a0Koo J. et al. J Dermatol Treat 2016;27(2):120-7 \u00a0\u00a0\u00a0\u00a0
(2)\u00a0Lind M et al; Dermatol Ther (Heidelb) 2016
\u00a9LEO Pharma JAN 2024 MAT-70737.\u00a0 All LEO Pharma trademarks mentioned belong to the LEO Pharma group.\u00a0 LEO Pharma nv\/sa. Duwijckstraat 17,2500 Lier<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Sujet : changements de prix et de remboursement pour Dovobet\u00ae, Xamiol\u00ae et Enstilum\u00ae Ch\u00e8re,Cher docteur, professeur, LEO Pharma investit depuis de nombreuses ann\u00e9es dans le d\u00e9veloppement de m\u00e9dicaments pour les affections cutan\u00e9es. Nos m\u00e9dicaments topiques pour le traitement du psoriasis sont la pierre angulaire du traitement de nombreux patients en Belgique. En raison de l’introduction […]<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_user_content_segmentation__post_segment_selection":[],"_trash_the_other_posts":false,"editor_notices":[],"leo_pharma_teaser_title":"","footnotes":""},"content_tag":[],"class_list":["post-204","page","type-page","status-publish","hentry"],"yoast_head":"\nLoE Communicatie | LEO Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LoE Communicatie | LEO Pharma\" \/>\n<meta property=\"og:description\" content=\"Sujet : changements de prix et de remboursement pour Dovobet\u00ae, Xamiol\u00ae et Enstilum\u00ae Ch\u00e8re,Cher docteur, professeur, LEO Pharma investit depuis de nombreuses ann\u00e9es dans le d\u00e9veloppement de m\u00e9dicaments pour les affections cutan\u00e9es. Nos m\u00e9dicaments topiques pour le traitement du psoriasis sont la pierre angulaire du traitement de nombreux patients en Belgique. En raison de l’introduction […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/\" \/>\n<meta property=\"og:site_name\" content=\"LEO Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-13T13:09:10+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture est.\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/\",\"url\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/\",\"name\":\"LoE Communicatie | LEO Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/#website\"},\"datePublished\":\"2026-08-13T13:08:44+00:00\",\"dateModified\":\"2026-08-13T13:09:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/#breadcrumb\"},\"inLanguage\":\"fr-BE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LoE Communicatie\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/#website\",\"url\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/\",\"name\":\"LEO Pharma\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-BE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/#organization\",\"name\":\"LEO Pharma\",\"url\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-BE\",\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/wp-content\\\/uploads\\\/sites\\\/26\\\/2026\\\/06\\\/download-1.svg\",\"contentUrl\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/wp-content\\\/uploads\\\/sites\\\/26\\\/2026\\\/06\\\/download-1.svg\",\"width\":94,\"height\":75,\"caption\":\"LEO Pharma\"},\"image\":{\"@id\":\"https:\\\/\\\/leo-pharma.be\\\/fr-be\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LoE Communicatie | LEO Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","og_locale":"fr_FR","og_type":"article","og_title":"LoE Communicatie | LEO Pharma","og_description":"Sujet : changements de prix et de remboursement pour Dovobet\u00ae, Xamiol\u00ae et Enstilum\u00ae Ch\u00e8re,Cher docteur, professeur, LEO Pharma investit depuis de nombreuses ann\u00e9es dans le d\u00e9veloppement de m\u00e9dicaments pour les affections cutan\u00e9es. Nos m\u00e9dicaments topiques pour le traitement du psoriasis sont la pierre angulaire du traitement de nombreux patients en Belgique. En raison de l’introduction […]","og_url":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","og_site_name":"LEO Pharma","article_modified_time":"2026-08-13T13:09:10+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture est.":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","url":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","name":"LoE Communicatie | LEO Pharma","isPartOf":{"@id":"https:\/\/leo-pharma.be\/fr-be\/#website"},"datePublished":"2026-08-13T13:08:44+00:00","dateModified":"2026-08-13T13:09:10+00:00","breadcrumb":{"@id":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/#breadcrumb"},"inLanguage":"fr-BE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/leo-pharma.be\/fr-be\/"},{"@type":"ListItem","position":2,"name":"LoE Communicatie"}]},{"@type":"WebSite","@id":"https:\/\/leo-pharma.be\/fr-be\/#website","url":"https:\/\/leo-pharma.be\/fr-be\/","name":"LEO Pharma","description":"","publisher":{"@id":"https:\/\/leo-pharma.be\/fr-be\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/leo-pharma.be\/fr-be\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-BE"},{"@type":"Organization","@id":"https:\/\/leo-pharma.be\/fr-be\/#organization","name":"LEO Pharma","url":"https:\/\/leo-pharma.be\/fr-be\/","logo":{"@type":"ImageObject","inLanguage":"fr-BE","@id":"https:\/\/leo-pharma.be\/fr-be\/#\/schema\/logo\/image\/","url":"https:\/\/leo-pharma.be\/fr-be\/wp-content\/uploads\/sites\/26\/2026\/06\/download-1.svg","contentUrl":"https:\/\/leo-pharma.be\/fr-be\/wp-content\/uploads\/sites\/26\/2026\/06\/download-1.svg","width":94,"height":75,"caption":"LEO Pharma"},"image":{"@id":"https:\/\/leo-pharma.be\/fr-be\/#\/schema\/logo\/image\/"}}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"WebPage","headline":"LoE Communicatie","url":"http:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/","mainEntityOfPage":{"@type":"WebPage","@id":"http:\/\/leo-pharma.be\/fr-be\/loe-communicatie\/"},"thumbnailUrl":"","image":{"@type":"ImageObject","url":""},"articleSection":"Uncategorized","author":[{"@type":"Person","name":"ntitus"}],"creator":["ntitus"],"publisher":{"@type":"Organization","name":"LEO Pharma","logo":""},"keywords":[],"dateCreated":"2026-08-13T13:08:44Z","datePublished":"2026-08-13T13:08:44Z","dateModified":"2026-08-13T13:09:10Z"},"rendered":"<script type=\"application\/ld+json\" class=\"wp-parsely-metadata\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"WebPage\",\"headline\":\"LoE Communicatie\",\"url\":\"http:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/leo-pharma.be\\\/fr-be\\\/loe-communicatie\\\/\"},\"thumbnailUrl\":\"\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"\"},\"articleSection\":\"Uncategorized\",\"author\":[{\"@type\":\"Person\",\"name\":\"ntitus\"}],\"creator\":[\"ntitus\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"LEO Pharma\",\"logo\":\"\"},\"keywords\":[],\"dateCreated\":\"2026-08-13T13:08:44Z\",\"datePublished\":\"2026-08-13T13:08:44Z\",\"dateModified\":\"2026-08-13T13:09:10Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/leo-pharma.be\/p.js"},"has_excerpt":false,"_links":{"self":[{"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/pages\/204","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/comments?post=204"}],"version-history":[{"count":2,"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/pages\/204\/revisions"}],"predecessor-version":[{"id":207,"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/pages\/204\/revisions\/207"}],"wp:attachment":[{"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/media?parent=204"}],"wp:term":[{"taxonomy":"content_tag","embeddable":true,"href":"https:\/\/leo-pharma.be\/fr-be\/wp-json\/wp\/v2\/content_tag?post=204"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}